- Report
- October 2025
- 90 Pages
North America
From €2846EUR$3,250USD£2,471GBP
- Report
- June 2025
- 89 Pages
North America
From €3022EUR$3,450USD£2,623GBP
- Report
- June 2025
- 81 Pages
Africa, Middle East
From €3022EUR$3,450USD£2,623GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2025
- 100 Pages
Europe
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2025
- 90 Pages
United States
From €1751EUR$1,999USD£1,520GBP
- Report
- February 2025
- 95 Pages
North America
From €5251EUR$5,995USD£4,557GBP
- Report
- February 2025
- 111 Pages
Europe
From €5251EUR$5,995USD£4,557GBP
- Report
- February 2025
- 107 Pages
Asia Pacific
From €5251EUR$5,995USD£4,557GBP
- Report
- November 2023
- 127 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €2049EUR$2,340USD£1,779GBP
€3153EUR$3,600USD£2,737GBP
- Report
- January 2023
- 127 Pages
Global
From €1971EUR$2,250USD£1,710GBP
- Report
- April 2021
Global
From €788EUR$900USD£684GBP
- Report
- March 2022
- 260 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- February 2024
- 78 Pages
Global
From €2584EUR$2,950USD£2,242GBP
- Report
- February 2020
- 237 Pages
Global
From €2409EUR$2,750USD£2,090GBP
- Report
- February 2024
- 158 Pages
Global
From €4073EUR$4,650USD£3,535GBP
- Report
- August 2023
- 336 Pages
Global
From €4073EUR$4,650USD£3,535GBP
- Report
- January 2020
- 54 Pages
Global
From €1730EUR$1,975USD£1,501GBP
- Report
- December 2022
- 66 Pages
Global
From €3065EUR$3,500USD£2,661GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more